News from beckman coulter diagnostics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 18, 2019, 07:00 ET Beckman Coulter's Early Sepsis Indicator Receives 510(k) Clearance from the U.S. Food and Drug Administration

A major milestone on its strategic mission to lead in sepsis diagnostics, Beckman Coulter today announced that its Early Sepsis Indicator has...


Mar 07, 2019, 07:00 ET Beckman Coulter's HbA1c Advanced Assay Provides Physicians with Greater Accuracy when Diagnosing Patients with Diabetes

Beckman Coulter, a global leader in the clinical diagnostics industry, today announced the latest addition to its comprehensive chemistry assay...


Oct 16, 2018, 08:30 ET Beckman Coulter Diagnostics Joins Forces with Johns Hopkins Medicine in Healthcare Innovation Initiative

Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, is embarking on an innovation collaboration with Johns Hopkins...


Jun 25, 2018, 09:00 ET Beckman Coulter Files a 510(k) Submission with the FDA for Its Early Sepsis Indicator*

Beckman Coulter announced that it has filed a submission for 510(k) clearance with the U.S. Food and Drug Administration (FDA) for its Early Sepsis...


Jun 19, 2018, 09:00 ET Pivotal Study Reveals Effectiveness of Blood Tests in Screening for Sleep Apnea in Adult Males

Beckman Coulter announced today the positive results of a clinical trial suggesting that blood tests may offer key benefits in the initial screening...


May 01, 2018, 11:35 ET Beckman Coulter Launches the DxH 900 Hematology Analyzer

Beckman Coulter announced today the release of the DxH 900 hematology analyzer, giving mid- to high-volume clinical laboratories the ability to...


Apr 17, 2018, 11:34 ET Beckman Coulter Sponsors Top-ranked Sepsis Clinical Guide App to Empower Clinicians Caring for Patients in Acute Settings

Beckman Coulter, a global leader in the clinical diagnostics industry, today announced its exclusive sponsorship of the ESCAVO Sepsis Clinical Guide...


Apr 10, 2018, 11:33 ET Beckman Coulter Diagnostics Announces Worldwide Commercialization of the Access Sensitive Estradiol

Beckman Coulter Diagnostics today announced commercialization of its Access Sensitive Estradiol in the U.S., with simultaneous commercial...


Jan 04, 2018, 11:33 ET Beckman Coulter Diagnostics Adds 6-Acetylmorphine (6-AM) and Buprenorphine (BUP) Assays to Comprehensive Chemistry Test Menu

Beckman Coulter Diagnostics today announced the addition of 6-Acetylmorphine (6-AM) and Buprenorphine (BUP) assays to its broad menu of...


Dec 21, 2017, 10:11 ET Beckman Coulter Diagnostics receives FDA clearance for the automated Access AMH Immunoassay to benefit fertility patients

Beckman Coulter Diagnostics announced FDA clearance of its automated Access AMH immunoassay for in vitro diagnostic (IVD) use in the U.S. This simple ...


Nov 28, 2017, 13:55 ET Beckman Coulter entre en litige commercial avec Quidel afin de vendre directement des tests de BNP

Beckman Coulter s'engage à garantir que ses clients bénéficient des tests de la plus haute qualité, dans les délais, afin d'aider les professionnels...


Nov 28, 2017, 12:20 ET Beckman entabla una disputa comercial con Quidel con vistas a encargarse de la venta directa de PNC

Beckman Coulter apuesta por que sus clientes puedan disponer a tiempo de análisis de la mayor calidad posible con el fin de contribuir a que los...


Nov 28, 2017, 09:46 ET Beckman Coulter leitet Handelsstreit mit Quidel über Direktvertrieb von BNP ein

Beckman Coulter ist fest entschlossen, seinen Kunden weiterhin erstklassige Assays zeitgerecht bereitzustellen, damit Ärzte und Labors ihre Patienten ...


Nov 28, 2017, 04:00 ET Společnost Beckman Coulter otevřela obchodní spor s firmou Quidel v souvislosti s přímým prodejem testů BNP

Společnost Beckman Coulter se zavázala zajistit, aby zákazníci dostávali testy nejvyšší kvality včas a ty pomohly zdravotnickým službám a odborníkům...


Nov 28, 2017, 03:22 ET Beckman Coulter rozpoczyna spór handlowy z Quidel o bezpośrednią sprzedaż BNP

Firma Beckman Coulter z zaangażowaniem pracuje nad zapewnianiem klientom najwyższej jakości analiz na czas w celu umożliwienia pracownikom opieki...


Nov 27, 2017, 18:32 ET Beckman Coulter entra em disputa comercial com a Quidel para vender BNP diretamente

A Beckman Coulter assumiu o compromisso de garantir aos clientes o recebimento de ensaios da mais alta qualidade, a tempo, para ajudar os...


Nov 27, 2017, 18:17 ET Beckman Coulter entabla disputa comercial con Quidel para vender BNP directamente

Beckman Coulter tiene el compromiso de asegurar que sus clientes reciban ensayos de la más alta calidad, a tiempo, para ayudar a los profesionales de ...


Nov 27, 2017, 16:16 ET Beckman Coulter инициирует коммерческий спор с Quidel по вопросу прямых продаж BNP

Компания Beckman Coulter прилагает все усилия для предоставления своевременного доступа к диагностическим анализам высочайшего качества и содействия...


Nov 27, 2017, 15:36 ET Beckman Coulter vstupuje do obchodného sporu s firmou Quidel v súvislosti s priamym predajom BNP

Spoločnosť Beckman Coulter sa zaviazala zabezpečiť, aby zákazníci dostávali testy najvyššej kvality včas, aby pomohli zdravotníckej starostlivosti a...


Nov 27, 2017, 13:40 ET Beckman Coulter Enters Commercial Dispute with Quidel to Sell BNP Directly

Beckman Coulter is committed to ensuring customers receive the highest quality assays, on-time, to help healthcare and laboratory professionals...


Nov 21, 2017, 08:00 ET Recently published study reports a significant reduction in biopsy procedures performed when Prostate Health Index (phi) testing is used by physicians in routine clinical practice

A study published in Prostate Cancer and Prostatic Diseases demonstrated that physicians elected to perform fewer biopsies when phi testing was...


Nov 07, 2017, 01:00 ET Beckman Coulter Diagnostics reçoit l'autorisation pour marquage CE de son dosage Access hsTnI ultra-sensible

Beckman Coulter Diagnostics a annoncé aujourd'hui avoir reçu l'autorisation de marque CE pour un nouveau dosage ultra-sensible de la troponine...


Nov 07, 2017, 01:00 ET Beckman Coulter Diagnostics erhält CE-Kennzeichnung für seinen hochsensitiven Access hsTnI-Assay

Beckman Coulter Diagnostics gab heute bekannt, dass das Unternehmen die CE-Kennzeichnung für seinen neuen, hochsensitiven Troponin hsTnI-Assay...


Nov 07, 2017, 01:00 ET Beckman Coulter Diagnostics obtiene autorización de la marca CE para su prueba Access hsTnl muy sensible

Beckman Coulter Diagnostics anunció hoy que ha recibido autorización de la marca CE para una nueva prueba de troponina (hsTnl) muy sensible que ayuda ...


Jun 21, 2017, 11:22 ET Beckman Coulter Diagnostics Expands Chemistry Menu to include FDA-cleared Procalcitonin (PCT)

Beckman Coulter Diagnostics along with partner Diazyme Laboratories announces FDA clearance of a new procalcitonin (PCT) assay, an important tool for ...